Literature DB >> 21940748

Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Li Ye1, Xu Wang, Jieliang Li, Jinping Liu, Servio H Ramirez, Jianguo Wu, Wenzhe Ho.   

Abstract

We investigated the ability of tetherin, a recently identified antiviral factor, in restricting hepatitis C virus (HCV) in the Japanese fulminant hepatitis-1 (JFH-1) infectious cell culture system. Human hepatocytes (Huh7, Huh7.5.1) expressedlow levels of endogenous tetherin, which could be induced by IFN-α. However, tetherin contributes little to IFN-α-mediated anti-HCV JFH-1 activity. Although tetherin could inhibit Vpu-deleted HIV-1 release, it had negligible activity in restricting HCV JFH-1 release from hepatocytes, which was evidenced by unaffected levels of intracellular/extracellular HCV RNA and infectious virus. The failure of tetherin's anti-HCV activity could not be related to the counteraction of HCV, as HCV infection of hepatocytes affected neither tetherin expression nor anti-HIV function of tetherin. These observations imply that tetherin has negligible activity in the restriction of HCV JFH-1 in human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940748      PMCID: PMC3937259          DOI: 10.1177/1753425911412984

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  43 in total

1.  Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Authors:  Li Ye; Shihong Wang; Xu Wang; Yu Zhou; Jieliang Li; Yuri Persidsky; Wenzhe Ho
Journal:  Drug Alcohol Depend       Date:  2010-06-20       Impact factor: 4.492

2.  Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways.

Authors:  Yin Chen; Edward Hamati; Pak-Kei Lee; Wai-Ming Lee; Shinichiro Wachi; David Schnurr; Shigeo Yagi; Gregory Dolganov; Homer Boushey; Pedro Avila; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

3.  Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1.

Authors:  W Z Ho; J Lioy; L Song; J R Cutilli; R A Polin; S D Douglas
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

5.  Morphine enhances hepatitis C virus (HCV) replicon expression.

Authors:  Yuan Li; Ting Zhang; Steven D Douglas; Jian-Ping Lai; Wei-Dong Xiao; David E Pleasure; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 6.  Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.

Authors:  Andrey Tokarev; Mark Skasko; Kathleen Fitzpatrick; John Guatelli
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

7.  Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.

Authors:  Hideki Aizaki; Ki-Jeong Lee; Vicky M-H Sung; Hiroaki Ishiko; Michael M C Lai
Journal:  Virology       Date:  2004-07-01       Impact factor: 3.616

8.  Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2.

Authors:  Stephanie T Shi; Ki-Jeong Lee; Hideki Aizaki; Soon B Hwang; Michael M C Lai
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network.

Authors:  Mathieu Dubé; Bibhuti Bhusan Roy; Pierre Guiot-Guillain; Johanne Mercier; Julie Binette; Grace Leung; Eric A Cohen
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

10.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

View more
  5 in total

1.  The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.

Authors:  Ran Yan; Xuesen Zhao; Dawei Cai; Yuanjie Liu; Timothy M Block; Ju-Tao Guo; Haitao Guo
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

2.  Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.

Authors:  Mingyu Lv; Biao Zhang; Ying Shi; Zhu Han; Yan Zhang; Yulai Zhou; Wenyan Zhang; Junqi Niu; Xiao-Fang Yu
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

Review 3.  Counteraction of the multifunctional restriction factor tetherin.

Authors:  Daniel Sauter
Journal:  Front Microbiol       Date:  2014-04-10       Impact factor: 5.640

4.  Type I interferon rapidly restricts infectious hepatitis C virus particle genesis.

Authors:  Luke W Meredith; Michelle J Farquhar; Alexander W Tarr; Jane A McKeating
Journal:  Hepatology       Date:  2014-10-27       Impact factor: 17.425

5.  Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.

Authors:  Caroline Blondeau; Annegret Pelchen-Matthews; Petra Mlcochova; Mark Marsh; Richard S B Milne; Greg J Towers
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.